Suppr超能文献

外耳道癌11种分期分类方法的比较。

Comparison of 11 staging classifications in carcinoma of the external auditory canal.

作者信息

Berpan Aniwat

机构信息

Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Dusit, Bangkok, 10300, Thailand.

出版信息

Eur Arch Otorhinolaryngol. 2025 Jun 2. doi: 10.1007/s00405-025-09489-4.

Abstract

BACKGROUND AND PURPOSE

To compare overall survival (OS) differences across 11 different staging classifications.

MATERIALS AND METHODS

Patient data were retrospectively collected. OS curves were estimated by Kaplan-Meier method. Hazard ratios (HR) were calculated by Cox regression. Concordance between HR of each system was evaluated by C-index. Absolute net reclassification improvement (NRI) was performed.

RESULTS

Thirty-five patients fitted study criteria with median follow-up of 27.3 months. 80% were diagnosed with squamous cell carcinoma. 14.3% had ECOG > 1. Eighteen patients underwent surgery, while 31 patients received radiotherapy. For AJCC 8th edition cutaneous carcinoma of the head and neck, 3-year OS of stage 1-3 and 4 was 26.7% (median OS of 0.8 years) and 64.1% (median OS of 4.3 years) (HR 0.33; 95%CI 0.09-1.2). 3-year OS of T1-3 and T4 in modified Pittsburgh classification were 65% and 55.4% with median OS of not reached and 3.1 years (HR 1.86; 95%CI 0.66-5.23). Regarding Kinney system, patients with stage 1-2 and 3 had 3-year OS of 67.1% and 45.5%, while median OS was 4.7 years and 1 year (HR 1.94; 95%CI 0.75-4.97). C-indices were 0.577, 0.523 and 0.569. NRI comparing Kinney with modified Pittsburgh classifications was 2.86%.

CONCLUSION

Kinney's may offer improved prognostic accuracy compared to other classifications.

摘要

背景与目的

比较11种不同分期分类的总生存期(OS)差异。

材料与方法

回顾性收集患者数据。采用Kaplan-Meier法估计OS曲线。通过Cox回归计算风险比(HR)。用C指数评估各系统HR之间的一致性。进行绝对净重新分类改善(NRI)分析。

结果

35例患者符合研究标准,中位随访时间为27.3个月。80%被诊断为鳞状细胞癌。14.3%的患者东部肿瘤协作组(ECOG)体能状态评分>1。18例患者接受了手术,31例患者接受了放疗。对于美国癌症联合委员会(AJCC)第8版头颈部皮肤癌,1-3期和4期的3年总生存率分别为26.7%(中位总生存期为0.8年)和64.1%(中位总生存期为4.3年)(HR 0.33;95%置信区间0.09-1.2)。改良匹兹堡分类中T1-3期和T4期的3年总生存率分别为65%和55.4%,中位总生存期未达到和3.1年(HR 1.86;95%置信区间0.66-5.23)。关于金尼系统,1-2期和3期患者的3年总生存率分别为67.1%和45.5%,而中位总生存期分别为4.7年和1年(HR 1.94;95%置信区间0.75-4.97)。C指数分别为0.577、0.523和

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验